Innovative treatments continue to shape how medical teams approach diabetic retinopathy, aiming for more than just slowing the progression of disease-related complications. One promising...
Diabetic retinopathy is among the most common causes of vision impairment and blindness in adults, triggered largely by chronic hyperglycemia and associated damage to...
Faricimab—marketed under the brand name Vabysmo—represents a cutting-edge approach to treating diabetes-related eye conditions. By leveraging a distinctive dual-action mechanism, it seeks to reduce...
A Novel Introduction to Exosome Therapy for Diabetic Retinopathy
Diabetic retinopathy (DR) remains one of the foremost causes of vision impairment among working-age adults worldwide....
Diabetic retinopathy often compromises daily life by impairing vision. Transcorneal Electrical Stimulation (TCE) is a specialized electrotherapy that sends low-level electrical pulses through the...